Yahoo! Finance: Commodity News

LONDON & PHILADELPHIA & CARLSBAD, Calif.----GlaxoSmithKline and Regulus Therapeutics LLC today announced a worldwide strategic alliance to discover, develop and market novel microRNA-targeted therapeutics to treat inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

complete story here...